Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
254 studies found for:    Open Studies | "Uterine Cervical Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Uterine Cervical Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients
Conditions: Uterine Cervical Neoplasms;   Cervical Cancer;   Uterine Cervical Cancer
Interventions: Procedure: radical hysterectomy + pelvic lymph node dissection;   Drug: Paclitaxel;   Drug: Cisplatin;   Radiation: Pelvic RT
2 Recruiting FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
Conditions: Cervical Cancer;   Uterine Cervical Cancer;   Uterine Cervical Neoplasms
Interventions: Device: FDG-PET/MR;   Device: FDG-PET/CT
3 Unknown  Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer
4 Recruiting MR Metabolic Biomarkers for Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention:
5 Recruiting MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Cancer;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: computed tomography
6 Recruiting Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
Conditions: Recurrent Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Drug: eribulin mesylate
7 Recruiting 2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial
Conditions: Uterine Cervical Neoplasms;   Laparoscopic Surgical Procedures
Interventions: Procedure: 3D Laparoscopy;   Procedure: Standard Laparoscopy
8 Recruiting AZD1775, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer
Conditions: Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer
Interventions: Drug: WEE1 Inhibitor MK-1775;   Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Pulsed-Dose Rate Brachytherapy;   Radiation: Internal Radiation Therapy;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis
9 Recruiting Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Vaginal Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma
Interventions: Drug: Triapine;   Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis
10 Recruiting Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Chemotherapeutic Agent Toxicity;   Cognitive Side Effects of Cancer Therapy;   Psychological Impact of Cancer;   Radiation Toxicity;   Sexual Dysfunction and Infertility;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Drug: Cisplatin;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Quality-of-Life Assessment
11 Recruiting Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Internal Radiation Therapy;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis
12 Recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
13 Recruiting Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IA Cervical Cancer;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis
14 Recruiting HPV-test, Cervical Cancer and Follow-up
Conditions: Human Papilloma Virus;   Uterine Cervical Neoplasms;   Recurrence
Intervention: Procedure: Human Papilloma Virus test from the vaginal vault
15 Recruiting Repetitive Functional Imaging in Locally Advanced Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention:
16 Not yet recruiting The Effect of Postoperative Therapy on the Quality of Life of Patients With Early Cervical Cancer Research
Condition: Uterine Cervical Neoplasms
Intervention:
17 Not yet recruiting Phase II Study of Pazopanib and Topotecan in Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Pazopanib;   Drug: Topotecan;   Behavioral: Phone Call
18 Unknown  Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Drug: 18F Fluoroazomycin Arabinoside (FAZA)
19 Recruiting Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiotherapy;   Drug: Cisplatin
20 Recruiting Smoking Cessation for Cervical Cancer Survivors
Condition: Cervical Cancer
Interventions: Behavioral: Self-Help Materials;   Drug: Nicotine Patch;   Behavioral: Questionnaire Design System (QDS);   Procedure: Saliva Test;   Behavioral: Telephone Counseling Sessions

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years